BG98933A - Cooled and atomized nabumetone - Google Patents
Cooled and atomized nabumetoneInfo
- Publication number
- BG98933A BG98933A BG98933A BG9893394A BG98933A BG 98933 A BG98933 A BG 98933A BG 98933 A BG98933 A BG 98933A BG 9893394 A BG9893394 A BG 9893394A BG 98933 A BG98933 A BG 98933A
- Authority
- BG
- Bulgaria
- Prior art keywords
- nabumetone
- atomized
- cooled
- far
- produced
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coating By Spraying Or Casting (AREA)
- Medicines Containing Plant Substances (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Freezing, Cooling And Drying Of Foods (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Sampling And Sample Adjustment (AREA)
- Catching Or Destruction (AREA)
- Road Signs Or Road Markings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929201857A GB9201857D0 (en) | 1992-01-29 | 1992-01-29 | Novel compound |
PCT/GB1993/000145 WO1993014747A1 (en) | 1992-01-29 | 1993-01-22 | Spray-chilled nabumetone |
Publications (1)
Publication Number | Publication Date |
---|---|
BG98933A true BG98933A (en) | 1995-07-28 |
Family
ID=10709436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG98933A BG98933A (en) | 1992-01-29 | 1994-07-28 | Cooled and atomized nabumetone |
Country Status (24)
Country | Link |
---|---|
US (1) | US5539000A (ja) |
EP (1) | EP0624087B1 (ja) |
JP (1) | JPH07503245A (ja) |
KR (1) | KR950700056A (ja) |
CN (1) | CN1079954A (ja) |
AT (1) | ATE150298T1 (ja) |
AU (1) | AU3362693A (ja) |
BG (1) | BG98933A (ja) |
BR (1) | BR9305674A (ja) |
CA (1) | CA2129027A1 (ja) |
CZ (1) | CZ182894A3 (ja) |
DE (1) | DE69309037T2 (ja) |
DK (1) | DK0624087T3 (ja) |
ES (1) | ES2099419T3 (ja) |
FI (1) | FI943550A0 (ja) |
GB (1) | GB9201857D0 (ja) |
GR (1) | GR3023142T3 (ja) |
HU (1) | HUT67462A (ja) |
IL (1) | IL104526A0 (ja) |
MX (1) | MX9300430A (ja) |
NO (1) | NO942813L (ja) |
SK (1) | SK91694A3 (ja) |
WO (1) | WO1993014747A1 (ja) |
ZA (1) | ZA93577B (ja) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030236236A1 (en) * | 1999-06-30 | 2003-12-25 | Feng-Jing Chen | Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
GB9920148D0 (en) * | 1999-08-25 | 1999-10-27 | Smithkline Beecham Plc | Novel composition |
US6552078B2 (en) | 1999-10-27 | 2003-04-22 | Nobex Corp | 6-methoxy-2-naphthylacetic acid prodrugs |
US6436990B1 (en) | 1999-10-27 | 2002-08-20 | Nobex Corporation | 6-methoxy-2-naphthylacetic acid prodrugs |
TWI262791B (en) | 1999-10-27 | 2006-10-01 | Nobex Corp | 6-methoxy-2-naphthylacetic acid prodrugs |
US20020132010A1 (en) * | 2000-12-22 | 2002-09-19 | Yihong Qui | Divalproex sodium dosage forms and a process for their production |
US20060083791A1 (en) * | 2002-05-24 | 2006-04-20 | Moerck Rudi E | Rare earth metal compounds methods of making, and methods of using the same |
US20040161474A1 (en) * | 2002-05-24 | 2004-08-19 | Moerck Rudi E. | Rare earth metal compounds methods of making, and methods of using the same |
US20040115287A1 (en) * | 2002-12-17 | 2004-06-17 | Lipocine, Inc. | Hydrophobic active agent compositions and methods |
DE602004014805D1 (de) * | 2003-12-04 | 2008-08-14 | Pfizer Prod Inc | Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten |
BRPI0416534A (pt) * | 2003-12-04 | 2007-01-09 | Pfizer Prod Inc | composições multiparticuladas com estabilidade melhorada |
BRPI0416535A (pt) * | 2003-12-04 | 2007-01-09 | Pfizer Prod Inc | processo de congelamento por vaporização empregando um extrusor para preparar composições de azitromicina de multiparticulado contendo preferivelmente um poloxámero e um glicerìdeo |
WO2005053639A2 (en) * | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Controlled release multiparticulates formed with dissolution enhancers |
ES2600577T3 (es) * | 2003-12-04 | 2017-02-09 | Bend Research, Inc. | Procedimiento de pulverización-solidificación que usa un extrusor para preparar composiciones en multipartículas de fármacos cristalinos |
CA2547239A1 (en) * | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Azithromycin multiparticulate dosage forms by liquid-based processes |
US6984403B2 (en) * | 2003-12-04 | 2006-01-10 | Pfizer Inc. | Azithromycin dosage forms with reduced side effects |
WO2005053652A1 (en) | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride |
CA2583548A1 (en) * | 2004-10-15 | 2006-04-27 | Altairnano, Inc. | Phosphate binder with reduced pill burden |
EP1928349A4 (en) * | 2005-08-17 | 2008-10-01 | Altairnano Inc | COMPOSITIONS AND METHODS FOR TREATING CHRONIC RENAL FAILURE AND OTHER CONDITIONS IN DOMESTIC ANIMALS |
US8217083B2 (en) * | 2007-06-08 | 2012-07-10 | Aptalis Pharma Canada Inc. | Mesalamine suppository |
US8436051B2 (en) * | 2007-06-08 | 2013-05-07 | Aptalis Pharma Canada Inc. | Mesalamine suppository |
US7541384B2 (en) * | 2007-06-08 | 2009-06-02 | Axcan Pharma Inc. | Mesalamine suppository |
US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
CN103037870B (zh) | 2010-05-12 | 2016-05-25 | 斯派克托姆制药公司 | 碱式碳酸镧、碳酸氧镧及其制造方法和用途 |
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
US9498485B2 (en) | 2014-08-28 | 2016-11-22 | Lipocine Inc. | Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters |
WO2016033549A2 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
US20180147215A1 (en) | 2016-11-28 | 2018-05-31 | Lipocine Inc. | Oral testosterone undecanoate therapy |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4420639C1 (en) * | 1973-09-11 | 2001-08-21 | Beecham Group Ltd | Aromatic compounds |
GB1474377A (en) | 1973-09-11 | 1977-05-25 | Beecham Group Ltd | Naphthalene derivatives |
US4086346A (en) * | 1974-04-06 | 1978-04-25 | Bayer Aktiengesellschaft | Preparation of melt-sprayed spherical phenacetin granules |
DE3833446A1 (de) | 1988-10-01 | 1990-04-05 | Hoechst Ag | Verfahren zur herstellung von arzneimittelwirkstoff-partikeln mit verbesserten fliess-, lager- und formulierungseigenschaften sowie arzneimittel, die diese arzneimittelwirkstoff-partikeln enthalten |
-
1992
- 1992-01-29 GB GB929201857A patent/GB9201857D0/en active Pending
-
1993
- 1993-01-22 CA CA002129027A patent/CA2129027A1/en not_active Abandoned
- 1993-01-22 ES ES93902444T patent/ES2099419T3/es not_active Expired - Lifetime
- 1993-01-22 AU AU33626/93A patent/AU3362693A/en not_active Abandoned
- 1993-01-22 DK DK93902444.4T patent/DK0624087T3/da active
- 1993-01-22 JP JP5513026A patent/JPH07503245A/ja active Pending
- 1993-01-22 AT AT93902444T patent/ATE150298T1/de active
- 1993-01-22 KR KR1019940702615A patent/KR950700056A/ko not_active Application Discontinuation
- 1993-01-22 BR BR9305674-5A patent/BR9305674A/pt unknown
- 1993-01-22 HU HU9402221A patent/HUT67462A/hu unknown
- 1993-01-22 US US08/030,331 patent/US5539000A/en not_active Expired - Fee Related
- 1993-01-22 WO PCT/GB1993/000145 patent/WO1993014747A1/en active IP Right Grant
- 1993-01-22 CZ CZ941828A patent/CZ182894A3/cs unknown
- 1993-01-22 DE DE69309037T patent/DE69309037T2/de not_active Expired - Fee Related
- 1993-01-22 EP EP93902444A patent/EP0624087B1/en not_active Expired - Lifetime
- 1993-01-22 SK SK916-94A patent/SK91694A3/sk unknown
- 1993-01-27 IL IL104526A patent/IL104526A0/xx unknown
- 1993-01-27 MX MX9300430A patent/MX9300430A/es unknown
- 1993-01-27 ZA ZA93577A patent/ZA93577B/xx unknown
- 1993-01-28 CN CN93100940A patent/CN1079954A/zh active Pending
-
1994
- 1994-07-28 NO NO942813A patent/NO942813L/no unknown
- 1994-07-28 FI FI943550A patent/FI943550A0/fi not_active Application Discontinuation
- 1994-07-28 BG BG98933A patent/BG98933A/xx unknown
-
1997
- 1997-04-15 GR GR970400804T patent/GR3023142T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CN1079954A (zh) | 1993-12-29 |
NO942813D0 (no) | 1994-07-28 |
ES2099419T3 (es) | 1997-05-16 |
GB9201857D0 (en) | 1992-03-18 |
MX9300430A (es) | 1994-08-31 |
FI943550A (fi) | 1994-07-28 |
CZ182894A3 (en) | 1995-02-15 |
HU9402221D0 (en) | 1994-09-28 |
CA2129027A1 (en) | 1993-08-05 |
ATE150298T1 (de) | 1997-04-15 |
WO1993014747A1 (en) | 1993-08-05 |
AU3362693A (en) | 1993-09-01 |
IL104526A0 (en) | 1993-05-13 |
JPH07503245A (ja) | 1995-04-06 |
HUT67462A (en) | 1995-04-28 |
DK0624087T3 (da) | 1997-09-01 |
KR950700056A (ko) | 1995-01-16 |
DE69309037D1 (de) | 1997-04-24 |
ZA93577B (en) | 1994-01-13 |
DE69309037T2 (de) | 1997-07-24 |
FI943550A0 (fi) | 1994-07-28 |
NO942813L (no) | 1994-07-28 |
BR9305674A (pt) | 2005-01-11 |
US5539000A (en) | 1996-07-23 |
GR3023142T3 (en) | 1997-07-30 |
SK91694A3 (en) | 1995-03-08 |
EP0624087A1 (en) | 1994-11-17 |
EP0624087B1 (en) | 1997-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG98933A (en) | Cooled and atomized nabumetone | |
AP1450A (en) | Solid oral dosage form comprising a combination of metformin and glibenclamide. | |
EP0494972A4 (en) | Effervescent dosage form and method of administering same | |
TW272195B (ja) | ||
MY102365A (en) | Di-t-butylphenol compounds. | |
HU9403323D0 (en) | 4-mercaptioacetylamino-[2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors | |
GB9410987D0 (en) | High dosage pharmaceutical compositions | |
FI950697A (fi) | IL-4:n ja/tai IL-10:n uudet käytöt ja vasta-aineet niitä vastaan | |
HK1002017A1 (en) | Lyospheres comprising gonadotropin | |
GR3023541T3 (en) | N,O-sulfated heparosanes; process to produce the same and pharmaceutical compositions containing them | |
MY109990A (en) | Microfluidised particles of atovaquone and pharmaceutical preparation thereof | |
EG18379A (en) | Novel pharmacological compounds | |
IL102337A0 (en) | Pyrrolpyrazines,their manufacture and pharmaceutical compositions containing them | |
IL104999A0 (en) | Substituted phenylacetamides,their preparation and pharmaceutical compositions containing them | |
MXPA94009086A (es) | Guanidinas sustituidas terapeuticas. | |
BG100248A (en) | Squalene synthetase inhibitors | |
EP0461261A4 (en) | MIXTURE OF OLIGOPEPTIDES AND PREPARATION CONTAINING SAME. | |
MD970269A (en) | Clavulanates | |
IL104418A0 (en) | Disubstituted polycyclic compounds and pharmaceutical compositions containing them | |
BG101849A (en) | Bicyclic tachyquinine antagonists, their preparation and use in pharmaceutical compositions | |
HUT65768A (en) | 17-beta-substituted 4-aza-androstane-derivatives and pharmaceutical compositions containing them and process for the production thereof | |
IL110780A0 (en) | Pharmaceutical compositions containing 1,3-bis(2-carboxy-chromon-5-yloxy)-propan-2-ol for the treatment of the common cold | |
TW218011B (ja) | ||
IT1199619B (it) | Vernici additivate | |
GB2252729B (en) | Vitamin and/or mineral containing pharmaceutical compositions |